Company: ARMP
Filing Date: 2025-05-14
Form Type: 8-K
Source: 0001558370-25-007752
Chunk: 1

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-05-14
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01

Financial Statements and Exhibits.

(d)Exhibits.

  Exhibit      Description                                                               
      No.                                                                                
     99.1      Press Release, dated May 14, 2025.                                        
 ─────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: May 14, 2025      Armata Pharmaceuticals, Inc.                                          
 ────────────────────────────────────────────────────────────────────────────────────────────────
                          By:                               /s/ David House                     
                          Name:                             David House                         
                          Title:                            Senior Vice President, Finance and